Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies (Q46735033)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies |
scientific article |
Statements
1 reference
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies (English)
1 reference
Jaap Verweij
1 reference
Isaiah J Fidler
1 reference
Ronald Hoekstra
1 reference
Herlinde Dumez
1 reference
Ferry A L M Eskens
1 reference
Ate van der Gaast
1 reference
Andre S T Planting
1 reference
Gerda de Heus
1 reference
Kurt C Sizer
1 reference
Christina Ravera
1 reference
Sujata Vaidyanathan
1 reference
Corazon Bucana
1 reference
Allan T van Oosterom
1 reference
1 October 2005
1 reference
11
1 reference
19 Pt 1
1 reference
6908-6915
1 reference